Dynamic micro-and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome

Journal of Applied Physiology

Volumn 113, Issue 7, 2012, Pages 1128-1140

  Trask, Aaron J ^a,b,e   Katz, Paige S ^a,c   Kelly, Amy P ^a   Galantowicz, Maarten L ^a   Cismowski, Mary J ^a,b   West, T Aaron ^a   Neeb, Zachary P ^d   Berwick, Zachary C ^d   Goodwill, Adam G ^d   Alloosh, Mouhamad ^d   Tune, Johnathan D ^d   Sturek, Michael ^d   Lucchesi, Pamela A ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTIN;

ANIMAL; ARTICLE; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; MALE; METABOLIC SYNDROME X; METABOLISM; MICROVASCULATURE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SWINE;

ANIMALS; BLOOD FLOW VELOCITY; COLLAGEN; CORONARY CIRCULATION; CORONARY VESSELS; ELASTIN; MALE; METABOLIC SYNDROME X; MICROVESSELS; OBESITY; SWINE;

EID: 84866992456     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00604.2012     Document Type: Article

References (55)

1. Bauersachs J, Bouloumie A, Mulsch A, Wiemer G, Fleming I, Busse R. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression and in superoxide anion production. Cardiovasc Res 37: 772-779, 1998.
2. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13: 968-972, 1989.
3. Belmadani S, Palen DI, Gonzalez-Villalobos RA, Boulares HA, Matrougui K. Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice. Diabetes 57: 1629-1637, 2008.
4. Belmadani S, Zerfaoui M, Boulares HA, Palen DI, Matrougui K. Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, v-3-integrin, and TGF-1 in response to ANG II and high glucose. Am J Physiol Heart Circ Physiol 295: H69-H76, 2008.
5. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH. Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234: 683-692, 2009.
6. Berwick ZC, Dick GM, Moberly SP, Kohr MC, Sturek M, Tune JD. Contribution of voltage-dependent K channels to metabolic control of coronary blood flow. J Mol Cell Cardiol 52: 912-919, 2012.
7. Berwick ZC, Dick GM, Tune JD. Heart of the matter: coronary dysfunction in metabolic syndrome. J Mol Cell Cardiol 52: 848-856, 2012.
8. Berwick ZC, Moberly SP, Kohr MC, Morrical EB, Kurian MM, Dick GM, Tune JD. Contribution of voltage-dependent K- and Ca2- channels to coronary pressure-flow autoregulation. Basic Res Cardiol 107: 1-11, 2012.
9. Borbouse L, Dick GM, Asano S, Bender SB, Dincer UD, Payne GA, Neeb ZP, Bratz IN, Sturek M, Tune JD. Impaired function of coronary BKCa channels in metabolic syndrome. Am J Physiol Heart Circ Physiol 297: H1629-H1637, 2009.
10. Bratz IN, Dick GM, Tune JD, Edwards JM, Neeb ZP, Dincer UD, Sturek M. Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol 294: H2489-H2496, 2008.
11. Bu DX, Rai V, Shen X, Rosario R, Lu Y, DAgati V, Yan SF, Friedman RA, Nuglozeh E, Schmidt AM. Activation of the ROCK1 branch of the transforming growth factor- pathway contributes to RAGEdependent acceleration of atherosclerosis in diabetic ApoE-null mice. Circ Res 106: 1040-1051, 2010.
12. Carroll JA, Daniel JA, Keisler DH, Matteri RL. Non-surgical catheterization of the jugular vein in young pigs. Lab Anim 33: 129-134, 1999.
13. Celik T, Iyisoy A, Yuksel UC. Pediatric metabolic syndrome: a growing threat. Int J Cardiol 142: 302-303, 2010.
14. Choi WS, Mitsumoto A, Kochevar IE. Involvement of reactive oxygen species in TGF-1-induced tropoelastin expression by human dermal fibroblasts. Photochem Photobiol 85: 1425-1433, 2009.
15. Dixon JL, Shen S, Vuchetich JP, Wysocka E, Sun GY, Sturek M. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J Lipid Res 43: 1618-1629, 2002.
16. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 19: 2981-2992, 1999.
17. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56: 35-45, 2006.
18. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report May 5: 1-7, 2009.
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
20. Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 33: 569-574, 1999.
21. Kassab GS, Choy JS, Svendsen M, Sinha AK, Alloosh M, Sturek M, Huo Y, Sandusky GE, Hermiller J. A novel system for the reconstruction of a coronary artery lumen profile in real time: a preclinical validation. Am J Physiol Heart Circ Physiol 297: H485-H492, 2009.
22. Katz PS, Trask AJ, Souza-Smith FM, Hutchinson KR, Galantowicz ML, Lord KC, Stewart JA Jr, Cismowski MJ, Varner KJ, Lucchesi PA. Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res Cardiol 106: 1123-1134, 2011.
23. Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen M, Piek JJ, Pijls NH, Siebes M, Spaan JA. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 114: 1321-1341, 2006.
24. Knudson JD, Dincer UD, Bratz IN, Sturek M, Dick GM, Tune JD. Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation 14: 317-338, 2007.
25. Kucich U, Rosenbloom JC, Abrams WR, Rosenbloom J. Transforming growth factor- stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-, and p38. Am J Respir Cell Mol Biol 26: 183-188, 2002.
26. Kuzuya M, Asai T, Kanda S, Maeda K, Cheng XW, Iguchi A. Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice. Diabetologia 44: 433-436, 2001.
27. Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker-Boudier HA. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 118: 968-976, 2008.
28. Marsh SA, Dellitalia LJ, Chatham JC. Interaction of diet and diabetes on cardiovascular function in rats. Am J Physiol Heart Circ Physiol 296: H282-H292, 2009.
29. Meloche J, Paulin R, Courboulin A, Lambert C, Barrier M, Bonnet P, Bisserier M, Roy M, Sussman MA, Agharazii M, Bonnet S. RAGEdependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol 31: 2114-2124, 2011.
30. Mokelke EA, Dietz NJ, Eckman DM, Nelson MT, Sturek M. Diabetic dyslipidemia and exercise affect coronary tone and differential regulation of conduit and microvessel K- current. Am J Physiol Heart Circ Physiol 288: H1233-H1241, 2005.
31. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension 28: 505-506, 1996.
32. Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H. Olmesartan, but not amlodipine, improves endothelium- dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 50: 1144-1149, 2007.
33. Neeb ZP, Edwards JM, Alloosh M, Long X, Mokelke EA, Sturek M. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med 60: 300-315, 2010.
34. Otis CR, Wamhoff BR, Sturek M. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp Med 53: 53-64, 2003.
35. Park Y, Yang J, Zhang H, Chen X, Zhang C. Effect of PAR2 in regulating TNF- and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice. Basic Res Cardiol 106: 111-123, 2011.
36. Payne GA, Borbouse L, Kumar S, Neeb Z, Alloosh M, Sturek M, Tune JD. Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C- pathway. Arterioscler Thromb Vasc Biol 30: 1711-1717, 2010.
37. Prior JO, Quinones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, Hsueh WA, Schelbert HR. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 111: 2291-2298, 2005.
38. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123: e18-e209, 2011.
39. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17: 1192-1200, 2004.
40. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-1108, 2008.
41. Senador D, Kanakamedala K, Irigoyen MC, Morris M, Elased KM. Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol 94: 648-658, 2009.
42. Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 39: 946-951, 1996.
43. Souza-Smith FM, Katz PS, Trask AJ, Stewart JA Jr, Lord KC, Varner KJ, Vassallo DV, Lucchesi PA. Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLos One 6: e23337, 2011.
44. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, Mc- Crindle B, Mietus-Snyder ML. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119: 628-647, 2009.
45. Sturek MAM, Wenzel J, Byrd JP, Edwards JM, Lloyd PG, Tune JD, March KL, Miller MA, Mokelke EA, Brisbin IL Jr. Ossabaw Island miniature swine: cardiometabolic syndrome assessment. In: Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques, edited by Swindle M. Boca Raton, FL: CRC, 2007, p. 397-402.
46. Takano M, Mizuno K, Okamatsu K, Yokoyama S, Ohba T, Sakai S. Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 38: 99-104, 2001.
47. Teragawa H, Mitsuba N, Nishioka K, Ueda K, Kono S, Higashi Y, Chayama K, Kihara Y. Impaired coronary microvascular endothelial function in men with metabolic syndrome. World J Cardiol 2: 205-210, 2010.
48. Wang R, Kudo M, Yokoyama M, Asano G. Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth. J Nihon Med Sch 68: 472-481, 2001.
49. Westerhof N, Boer C, Lamberts RR, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev 86: 1263-1308, 2006.
50. Witczak CA, Mokelke EA, Boullion R, Wenzel J, Keisler DH, Sturek M. Noninvasive measures of body fat percentage in male Yucatan swine. Comp Med 55: 445-451, 2005.
51. Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, Vasan S, Egan JJ, Ulrich P, Cerami A, Levy BI. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95: 4630-4634, 1998.
52. Wong ND, Rozanski A, Gransar H, Miranda-Peats R, Kang X, Hayes S, Shaw L, Friedman J, Polk D, Berman DS. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care 28: 1445-1450, 2005.
53. Yoon YW, Kang TS, Lee BK, Chang W, Hwang KC, Rhee JH, Min PK, Hong BK, Rim SJ, Kwon HM. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med 40: 398-406, 2008.
54. Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 84: 1984-1992, 1991.
55. Zhou F, Li GY, Gao ZZ, Liu J, Liu T, Li WR, Cui WS, Bai GY, Xin ZC. The TGF-1/Smad/CTGF pathway and corpus cavernosum fibrousmuscular alterations in rats with streptozotocin-induced diabetes. J Androl 33: 651-659, 2012.